Nisen Perry bought TEVA
June 6, 2024 · Form 4 insider transaction
Nisen Perry bought 9,632 shares of Teva Pharmaceutical Industries Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,632
Price
$0.00
Total value
N/A
InsiderNisen Perry
RoleDirector
SecurityRestricted Share Units
Transaction codeA: Grant or award
Transaction dateJune 6, 2024
Filing dateJune 10, 2024
Shares owned after9,632
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.; Restricted share units were granted on June 6, 2024 and vest on June 6, 2025.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.